AmotL2 disrupts apical–basal cell polarity and promotes tumour invasion
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AmotL2 disrupts apical–basal cell polarity and promotes tumour invasion
Authors
Keywords
-
Journal
Nature Communications
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-01
DOI
10.1038/ncomms5557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion
- (2014) Sara Hultin et al. Nature Communications
- Anti-angiogenesis and metastasis: a tumour and stromal cell alliance
- (2013) L. Moserle et al. JOURNAL OF INTERNAL MEDICINE
- Tumor Type-Dependent Function of the Par3 Polarity Protein in Skin Tumorigenesis
- (2012) Sandra Iden et al. CANCER CELL
- Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis
- (2012) Luke Martin McCaffrey et al. CANCER CELL
- Loss of Par3 promotes breast cancer metastasis by compromising cell–cell cohesion
- (2012) Bin Xue et al. NATURE CELL BIOLOGY
- Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells
- (2012) Samit Chatterjee et al. PLoS One
- Epithelial cell polarity: a major gatekeeper against cancer?
- (2011) C Royer et al. CELL DEATH AND DIFFERENTIATION
- Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
- (2011) B. Zhao et al. GENES & DEVELOPMENT
- SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia
- (2011) Helen B. Pearson et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
- (2011) Murugan Paramasivam et al. MOLECULAR BIOLOGY OF THE CELL
- A specific role for Arabidopsis TRAPPII in post-Golgi trafficking that is crucial for cytokinesis and cell polarity
- (2011) Xingyun Qi et al. PLANT JOURNAL
- Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome
- (2011) C. J. Westlake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
- (2010) Wenqi Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cdc42 localization and cell polarity depend on membrane traffic
- (2010) Naël Osmani et al. JOURNAL OF CELL BIOLOGY
- Recycling endosomes in apical plasma membrane domain formation and epithelial cell polarity
- (2010) Magdalena R. Golachowska et al. TRENDS IN CELL BIOLOGY
- Angiomotin-Like Protein 1 Controls Endothelial Polarity and Junction Stability During Sprouting Angiogenesis
- (2009) Yujuan Zheng et al. CIRCULATION RESEARCH
- The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells
- (2008) M. Ernkvist et al. BLOOD
- Role of the Polarity Determinant Crumbs in Suppressing Mammalian Epithelial Tumor Progression
- (2008) C. M. Karp et al. CANCER RESEARCH
- Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis
- (2008) Yuanmei Lou et al. DEVELOPMENTAL DYNAMICS
- Cell polarity and cancer - cell and tissue polarity as a non-canonical tumor suppressor
- (2008) M. Lee et al. JOURNAL OF CELL SCIENCE
- From cells to organs: building polarized tissue
- (2008) David M. Bryant et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
- (2008) P. Vaupel ONCOLOGIST
- Polarity complex proteins
- (2007) Emeline Assémat et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More